Hybrid closed-loop insulin therapy improves glycemic control

(Mary Ann Liebert, Inc./Genetic Engineering News) Hybrid closed-loop insulin therapy improved glycemic control in adolescents and young adults with type 1 diabetes. These outcomes, derived from the International Diabetes Closed-Loop (iDCL)